NCT00148746

Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: —
• Sponsor: Technische Universität Dresden · Academic / Other
• Sex: All
• Age: 2 Years
• Healthy volunteers: Not accepted

Summary

The study was designed to test the hypothesis whether a standardized, time-and score-oriented treatment following a strict evidence based algorithm is equally effective to a standard treatment regimen for moderate to severe atopic dermatitis. Study Type: Mono-centre study, patients are blinded, physicians are randomized to either treat study- or controll group Eligible are patients age 2 years or older with SCORAD \>= 20 Duration: 12 Months, study visits every 4 weeks. Primary endpoint is Difference between Baseline SCORAD and mean SCORAD under treatment. Secundary endpoints are quality of life, safety and economic burden in both treatment groups.

Conditions

• Moderate to Severe Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	Pimecrolimus
DRUG	Tacrolimus
DRUG	Prednisolone
DRUG	Ciclosporin A
DRUG	Dermatop

Timeline

• Start date: 2004-05-01
• Primary completion: 2006-09-01
• Completion: 2008-03-01
• First posted: 2005-09-08
• Last updated: 2010-06-09

Locations

1 site across 1 country: Germany